NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/23/2026
Back to search
Official data from USPTO
PF 72
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/17/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
02/02/2018
Registration date
04/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/23/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Seoul, KR
Examiner
SEVERSON, JUSTIN
Current location
Historical data usage
Mark description
The mark consists of the letters "PF" and the numbers "72" separated by a shaded rectangle, arranged vertically.
Holders and representatives
Holders
Tgel Bio Co., Ltd.
Tgel Bio Co., Ltd.
Representatives
John P. McCormick Fish & Richardson P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; microspheres used as vehicles to deliver drugs in the nature of pharmaceutical preparations; pharmaceutical preparations and substances for use in drug delivery in cell and tissue; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substancesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery formulations in the form of tabletscapsulessolutionssuspensionspellets with tamper resistant properties which facilitate or allow the delivery of a wide range of pharmaceuticals; peptides for drug deliverydrug delivery agents consisting of peptides attached to drugs that facilitate delivery of pharmaceutical preparations; carriers for drug deliverydrug delivery agent in the form of nanoparticle for transferring siRNA in the cell; drug delivery agents that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals ; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals
Class 10
Drug delivery apparatus for medical purposesusing microspheres for embolization; electromagnetic drug delivery apparatus for medical use; drug infusion pump; drug delivery devices; implantable drug delivery pump for use as drug delivery device sold empty; implantable medication infuser for use as drug delivery device sold empty; drug delivery platforms; implantable subcutaneous drug delivery devices sold empty; anaesthetic delivery apparatus; medical drug syringes; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for facilitating the inhalation of pharmaceutical preparations; surgical instruments and apparatus; medical products being medical syringes; implants consisting of artificial materials; orthopedic articlesorthopedic walkers and orthopedic supports
Publications
History of USPTO decisions and trademark events.
40 publications found
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
02/23/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2026
ES71
TEAS SECTION 71 RECEIVED
10/30/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/30/2024
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
06/30/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/16/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/13/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/06/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/18/2020
FIMP
FINAL DISPOSITION PROCESSED
02/18/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/18/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/16/2019
PLGL
ASSIGNED TO PARALEGAL
10/16/2019
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
09/25/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2019
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
05/13/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/12/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/12/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
02/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/23/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/26/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/21/2018
RFNT
REFUSAL PROCESSED BY IB
07/07/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/21/2018
RFRR
REFUSAL PROCESSED BY MPU
06/21/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/14/2018
CNRT
NON-FINAL ACTION WRITTEN
06/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2018
DOCK
ASSIGNED TO EXAMINER
06/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/07/2018
Continuous trademark protection
Get notified about every new filing that threatens PF 72 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.